Document is current

Article History

Received: 11 June 2021

Accepted: 22 August 2021

First Online: 16 September 2021

Declarations

:

: The Internal Review Board and the Ethics and Scientific Committee at the School of Medicine of the <i>Pontificia Universidad Catolica de Chile</i> approved this research (CEC MED UC approval number 16–046, resolution dated April 21, 2016) [CitationRef removed]. All participants signed an informed consent to participate in this study. Also, Internal Review Board and the Ethics and Scientific Committee at the School of Medicine of the <i>Pontificia Universidad Catolica de Chile</i> granted the waiver for the informed consent and the permission to access patients’ electronic medical records to include deceased patients. All data were anonymized to protect patients’ privacy. This study strictly adhered to the Code of Ethics of the World Medical Association (Declaration of Helsinki, 1964).

: Not applicable.

: MG is an advisor for Merck Sharp & Dohme and Novartis, participates at the speakers’ bureau for Bristol-Myers & Squibb and Bayer. Also receives research funding from Bristol-Myers & Squibb (Inst) and Novartis (Inst). Also, has received travel accommodations and expenses from Roche. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The other authors have no conflicts of interest to declare.